| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $64.4M | +12.1% |
| R&D Expense | $37.6M | -7.3% |
| SG&A Expense | $69.2M | -1.3% |
| Operating Income | -$46.9M | +16.2% |
| Pre-tax Income | -$44.6M | +9.4% |
| Income Tax | $11.8M | +99.3% |
| Net Income | -$56.4M | -2.2% |
| EPS (Basic) | -$1.15 | -15.0% |
| EPS (Diluted) | -$1.15 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.8M | -4.4% |
| Current Assets | $161.1M | +20.6% |
| Total Assets | $354.2M | -7.3% |
| Current Liabilities | $32.1M | +29.5% |
| Stockholders' Equity | $175.5M | -17.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.5M | +57.3% |
| Investing Cash Flow | $12.3M | +137.6% |
| Financing Cash Flow | -$2.5M | +98.7% |
| -15.0% |